the plasma membranes of cells is followed by rapid transport of LPS to a perinuclear site.
Moreover, this transport was absent from cells from mice with a genetic deficiency in responsiveness to LPS. 4 The mechanism for selective recognition and transport of LPS (or any membrane lipid) is not known at this time and is an area of active research.
Is LPS in membranes recognized as a monomer through stoichiometric, stereospecific binding with a defined binding partner or 'receptor?' This sentiment dominates the field, but another alternative must be considered. LPS might be recognized not as a monomer but as an array, or complex with itself or other membrane lipids. In this model, the spacing of groups and/or the collective properties of the complex are the features of LPS recognized by cells. An argument in favor of this hypothesis is the observation that deacylation of LPS changes not only the hydrophilic/lipophilic balance of the molecules but also transforms LPS from an agonist to an antagonist. Moreover, a small hydrophobic region is a common property of LPS antagonists such as Rhodobacter sphaeroides LPS (RsLPS). The composition and size of the hydrophobic portion of LPS will have large effects on its interaction with a plasma lipid bilayer. To test the hypothesis that the hydrophobic mass of LPS contributes to its recognition by cells, we have added the membrane-active agent chlorpromazine to cells treated with RsLPS. Chlorpromazine has a very large hydrophobic region and a small, cationic hydrophilic region. We observed that chlorpromazine both restored the ability of RsLPS to be transported to a perinuclear area and restored the ability of RsLPS to initiate cellular responses. 3 These studies make it clear that the properties of the membrane bearing LPS are key to recognition. They suggest first, that LPS, because of its large hydrophobic areas, may alter the physical properties of a membrane in which it resides and, thereby, initiate cellular responses. It further suggests that cellular responses may not require a stoichiometric, stereospecific interaction with a receptor since recognition normally enabled by covalently linked acyl chains (the 'piggy-backed fatty acids') can apparently be substituted by the noncovalently linked heterocyclic group of chlorpromazine. The ability to make such a drastic substitution is not consistent with the action of a classical receptor of high specificity and affinity. For these reasons, we prefer the hypothesis that cells discriminate bacterial lipids from host lipids on the basis of their interaction with and packing within a host lipid bilayer. UDP-N-acetylglucosamine (UDP-GlcNAc) 3-O-acyltransferase, product of the lpxA gene, catalyzes the first step in lipid A biosynthesis in Gram-negative bacteria -the transfer of an hydroxyacyl chain from acyl-acyl carrier protein (acyl-ACP) to the 3-OH position of UDP-GlcNAc. 1 This acyl chain becomes the 3 and 3′ acyl chains of mature lipid A. 2 In Escherichia coli lipid A, the 3 and 3′ acyl chains are always R-3-hydroxymyristate (3-OH-C14) and, accordingly, E. coli LpxA is very specific for 3-OH-C14-ACP over acyl-ACP of other chain lengths.
Acyl chain length specificity of UDP-Nacetylglucosamine 3-O-acyltransferases
1 However, the 3 and 3′ positions of lipid A from Neisseria meningitidis and Pseudomonas aeruginosa are substituted with 3-OH-C12 and 3-OH-C10, respectively. 3, 4 The LpxA enzymes from these organisms are highly specific for the acyl-ACP thioester of the chain length that matches the lipid A structure. 5, 6 By looking for conserved differences between amino acid sequences of long-and short-chain specific LpxAs, we identified G173 of the E. coli enzyme as potentially involved in acyl chain length specificity. It is completely conserved among all long-chain specific enzymes and is a large hydrophobic residue in the N. meningitidis and P. aeruginosa enzymes. Using site directed mutagenesis, we changed G173 of the E. coli LpxA to the corresponding residue from the P. aeruginosa enzyme, methionine. While the wild type E. coli enzyme prefers 3-OH-C14-ACP, the G173M mutant prefers 3-OH-C10-ACP over 3-OH-C14 (Table 1) . LpxAs were expressed in Corynebacterium glutamicum. Extracts were prepared by French press and assayed as described 5 using R,S-hydroxyacyl-ACP thioesters as acyl donor substrates.
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Given the importance of G173 to the acyl chain length specificity of the E. coli LpxA, we made the reciprocal change to the P. aeruginosa enzyme, changing the methionine at the equivalent position, 169, to the E. coli residue, glycine. The M169G mutant prefers 3-OH-C14-ACP over 3-OH-C10-ACP (Table 1) .
We were interested in confirming the specificity reversals in vivo. E. coli strain RO138 (lpxA2 recA) 5 produces wild type lipid A (mass = 1797) when grown at 30°C, but at 42°C has little LpxA activity, produces very little lipid A, and dies rapidly. 7 However, the temperature-sensitivity of RO138 can be corrected by a plasmid copy of E. coli lpxA. If RO138 is covered with a plasmid copy of P. aeruginosa lpxA, the strain also survives at 42°C, but produces lipid A with a mass of 1685, corresponding to 3-OH-C10 at the 3 and 3′ positions. 6 We transformed RO138 with plasmids encoding the G173M and M169G mutant LpxAs. Both strains survive at 42°C. RO138/ pG173M produces lipid A with a mass of 1685, while RO138/pM169G produces lipid A with a mass of 1797. Thus, the same specificity reversal seen by in vitro assay can be demonstrated in living cells.
A single amino acid change (G173M) can reverse the acyl chain length specificity of E. coli LpxA by 10 6 -fold. The reciprocal change to the P. aeruginosa enzyme (M169G) reverses its specificity by 10 5 fold. The reversal can be demonstrated both in vitro and in vivo. The in vivo studies in strain RO138 suggest the possibility of using similar acyl chain length specificity mutants of other lipid A acyltransferases to produce biologically interesting lipid A analogs easily and efficiently in living cells.
Nitric oxide (NO) is a free radical messenger produced by NO synthases (NOS) from the precursor L-arginine. An inducible NOS (iNOS), whose expression is driven by inflammatory mediators, such as endotoxin, has been associated with the hypotension of septic shock. The vasodilatory effect of NO relies on the direct activation of soluble guanylate cyclase and is cGMP-dependent. NO also has an incompletely defined role in inflammation. The regulation of inflammatory responses by NO has implications for the use of NOS inhibitors in septic shock, and the administration of inhaled NO in acute respiratory distress syndrome. In a series of investigations, we have studied the regulation of tumor necrosis factor (TNFα) by NO.
First, we studied the effect of exogenous NO on LPSinduced TNFα production in human neutrophil preparations. 1 Human neutrophils exposed to LPS and INF-γ did not show measurable increases in intracellular cGMP. However, cGMP increased up to 30-fold (P <0.01) in neutrophils incubated with both the NO donor sodium nitroprusside (SNP) and N-acetylcysteine (NAC), a thiol that increases the bioavailability of NO. The increase in cGMP
